Publications by authors named "E K Malone"

The Association of American Veterinary Medical Colleges competency-based veterinary education (CBVE) framework can be used to guide curriculum and assessment design and is intended to prepare veterinary graduates for Day One of clinical practice. However, while the framework defines curricular outcomes in terms of demonstrable competencies, it does not define the specific knowledge, skills, and attitudes required to achieve those outcomes. In some human medical curricula, prioritized lists of clinical presentations guide curricular content, design, and assessment.

View Article and Find Full Text PDF

The fission yeast Schizosaccharomyces pombe and the budding yeast Saccharomyces cerevisiae are highly diverged (530 mya), single-celled, model eukaryotic organisms. Scientists employ mating, meiosis, and the plating of ascospores and cells to generate strains with novel genotypes and to discover biological processes. Our three laboratories encountered independently sudden-onset, major impediments to such research.

View Article and Find Full Text PDF

Discrete DNA sites position meiotic recombination at hotspots. We sought to create four different, 15 bp long, candidate regulatory DNA sites within the reporter gene. Each effort employed a fission yeast-optimized CRISPR system (SpEDIT), optimal guide RNA, and one of four homologous recombination templates with 10 to 15 bp substitutions.

View Article and Find Full Text PDF

G-quadruplexes (G4s) formed by guanine-rich nucleic acids induce genome instability through impeding DNA replication fork progression. G4s are stable DNA structures, the unfolding of which require the functions of DNA helicases. Pif1 helicase binds preferentially to G4 DNA and plays multiple roles in maintaining genome stability, but the mechanism by which Pif1 unfolds G4s is poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • The phase 1b METSSAR trial evaluated a split-dose schedule of selinexor for advanced soft tissue sarcoma patients, aiming to reduce toxicity while maintaining efficacy.
  • The new dosing regimen showed no grade ≥ 3 treatment-related adverse events (TRAEs), and only mild toxicities like nausea and fatigue were reported, with some patients needing dose reductions.
  • Patients experienced a median progression-free survival of 4 months, indicating that the new schedule was tolerable and potentially more beneficial than the standard dosing.
View Article and Find Full Text PDF